Lymphoma, Large Cell Completed Phase 2 Trials for SGN-30 (DB05471)

Also known as: Large Cell Lymphoma / Lymphoma, Large-Cell / Large-cell Lymphoma

IndicationStatusPhase
DBCOND0032452 (Lymphoma, Large Cell)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00099255Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell LymphomaTreatment